Bydureon 2MG Suspension


Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 90.2%
Diabetes Mellitus 7.4%
Blood Glucose Increased 1.6%
Barrett's Oesophagus 0.8%
Injection Site Nodule 17.6%
Weight Decreased 14.4%
Injection Site Swelling 10.5%
Underdose 8.5%
Product Quality Issue 6.5%
Injection Site Haemorrhage 5.2%
Injection Site Pain 5.2%
Injection Site Pruritus 5.2%
Injection Site Reaction 3.9%
Nausea 3.3%
Drug Ineffective 2.6%
Injection Site Mass 2.6%
Pancreatitis 2.6%
Wrong Technique In Drug Usage Process 2.6%
Injection Site Extravasation 2.0%
Vomiting 2.0%
Adverse Event 1.3%
Anaphylactic Reaction 1.3%
Blood Glucose Increased 1.3%
Drug Dose Omission 1.3%

Drug Data